PlainPharmaWatch

CMS Open Payments · Tool

Alimera Sciences, Inc. vs PolyNovo North America LLC

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

PolyNovo North America LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 315, versus 287 for the other company. Its single largest recorded recipient represents 0.1% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Alimera Sciences, Inc.
HHI 287 · top recipient 0.1%
Ranked #1,470 of 1,838 companies by HHI
PolyNovo North America LLC
HHI 315 · top recipient 0.1%
Ranked #1,443 of 1,838 companies by HHI

Payment Overview

Total Payments
$2.0M
% of Industry
0.0%
Transactions
4,187
Avg per Transaction
$467.35
Recipients
3,868
Avg per Recipient
$505.89
Payment Types
3
Top Payment Type
Honoraria
Total Payments
$2.0M
% of Industry
0.0%
Transactions
7,446
Avg per Transaction
$262.77
Recipients
5,925
Avg per Recipient
$330.22
Payment Types
4
Top Payment Type
Food and Beverage

Highlighted values indicate the higher figure for each metric.

Total payments compared

Alimera Sciences, Inc. vs PolyNovo North America LLC - total reported payments in CMS Open Payments PY2024

Alimera Sciences, Inc.$2.0MPolyNovo North America LLC$2.0M

Payment Types Breakdown

Alimera Sciences, Inc.

Honoraria $573.8K

29.3%

Food and Beverage $211.2K

10.8%

Travel and Lodging $6.8K

0.3%

PolyNovo North America LLC

Food and Beverage $408.0K

20.9%

Consulting Fee $362.5K

18.5%

Travel and Lodging $53.8K

2.8%

Compensation for Faculty or Speaker (Medical Education) $3.4K

0.2%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Alimera Sciences, Inc.

  1. 1

    LISA FAIA

    $79,428.55 · 35 txns

  2. 2

    MARK DACEY

    $66,928.73 · 25 txns

  3. 3

    JORGE FORTUN

    $38,854.00 · 10 txns

  4. 4

    STEPHEN ANESI

    $28,213.96 · 24 txns

  5. 5

    DONALD MAZZULLA

    $25,054.12 · 26 txns

PolyNovo North America LLC

  1. 1

    SHAUN MENDENHALL

    $90,718.27 · 48 txns

  2. 2

    PAUL KIM

    $72,808.75 · 27 txns

  3. 3

    KYLE CHEPLA

    $61,175.96 · 29 txns

  4. 4

    MARK S GRANICK

    $33,828.78 · 16 txns

  5. 5

    WILLIAM HICKERSON

    $30,000.00 · 6 txns

Summary Comparison

Metric Alimera Sciences, Inc. PolyNovo North America LLC
Total Payments $2.0M $2.0M
% of Industry Total 0.0% 0.0%
Transaction Count 4,187 7,446
Avg per Transaction $467.35 $262.77
Recipient Count 3,868 5,925
Avg per Recipient $505.89 $330.22
Payment Type Count 3 4
Top Payment Type Honoraria Food and Beverage

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.